Holen Sie sich die Stockscreener-App
33.44
3.70%
-1.06
Schlusskurs vom Vortag:
$34.50
Offen:
$34.36
24-Stunden-Volumen:
103.51K
Relative Volume:
0.17
Marktkapitalisierung:
$1.39B
Einnahmen:
$115.18M
Nettoeinkommen (Verlust:
$-36.77M
KGV:
-33.11
EPS:
-1.01
Netto-Cashflow:
$-35.35M
1W Leistung:
-7.30%
1M Leistung:
-15.18%
6M Leistung:
-34.99%
1J Leistung:
-28.78%
1-Tages-Spanne:
$33.00
$34.51
1-Wochen-Bereich:
$33.00
$37.13
52-Wochen-Spanne:
$33.00
$66.54
Rxsight Inc Stock (RXST) Company Profile
Firmenname
Rxsight Inc
Sektor
Branche
Telefon
949-521-7822
Adresse
100 COLUMBIA STREET, ALISO VIEJO
Vergleichen Sie RXST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
33.35 | 1.39B | 115.18M | -36.77M | -35.35M | -1.01 |
|
ABT
Abbott Laboratories
|
112.86 | 196.55B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
95.74 | 141.03B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
366.70 | 138.80B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
81.52 | 104.60B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.39 | 43.28B | 6.60B | 4.16B | 490.10M | 6.93 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-10-29 | Eingeleitet | Jefferies | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-05-07 | Bestätigt | BTIG Research | Buy |
| 2023-12-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-04-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
Alle ansehen
Rxsight Inc Aktie (RXST) Neueste Nachrichten
How the (RXST) price action is used to our Advantage - Stock Traders Daily
RxSight, Inc. (NASDAQ:RXST) institutional owners may be pleased with recent gains after 2.8% loss over the past year - Simply Wall St
RxSight, Inc. To Present At The J.P. Morgan Healthcare Conference - Barchart
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference - The Manila Times
RxSight (NASDAQ:RXST) Hits New 1-Year LowHere's Why - MarketBeat
Trading (RXST) With Integrated Risk Controls - Stock Traders Daily
Geode Capital Management LLC Raises Stock Holdings in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight, Inc. (NASDAQ:RXST) Shares Purchased by Geode Capital Management LLC - MarketBeat
Barclays PLC Acquires 46,783 Shares of RxSight, Inc. (NASDAQ:RXST) - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Shares Bought by Barclays PLC - Defense World
MML Investors Services LLC Invests $452,000 in RxSight, Inc. (NASDAQ:RXST) - Defense World
RxSight (NASDAQ:RXST) Cut to Hold at Stifel Nicolaus - Defense World
RxSight (NASDAQ:RXST) Sets New 12-Month Low – What’s Next? - Defense World
RxSight, Inc. (NASDAQ:RXST) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
RxSight, Inc. (NASDAQ:RXST) Shares Bought by State Street Corp - MarketBeat
RxSight cut to hold at Stifel on competition concerns - MSN
RxSight stock touches 52-week low at $34.68 amid market shifts - Investing.com Australia
Stifel Downgrades RxSight (RXST) - MSN
Midday Stock Roundup: Mullen Down 10% Since Last Week’s Sales Update - Orange County Business Journal
RxSight Enters Oversold Territory (RXST) - Nasdaq
RxSight stock cut to hold at Stifel (RXST:NASDAQ) - Seeking Alpha
RxSight (NASDAQ:RXST) Reaches New 52-Week LowShould You Sell? - MarketBeat
RxSight stock touches 52-week low at $34.68 amid market shifts By Investing.com - Investing.com South Africa
Do You Believe in the Long-Term Growth Potential of RxSight (RXST)? - Insider Monkey
Forecasting The Future: 4 Analyst Projections For RxSight - Benzinga
Positive week for RxSight, Inc. (NASDAQ:RXST) institutional investors who lost 1.6% over the past year - Yahoo Finance
HighTower Advisors LLC Purchases 3,571 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World
Stifel downgrades RxSight stock on slowing LAL adoption projections - Investing.com
Stifel Downgrades RxSight Inc. (RXST) to Hold - StreetInsider.com
RxSight (NASDAQ:RXST) Trading Down 0.7%What's Next? - MarketBeat
RxSight (NASDAQ:RXST) Trading 3.7% HigherWhat's Next? - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Shares Sold by Lord Abbett & CO. LLC - MarketBeat
RxSight (NASDAQ:RXST) Stock Price Up 1.3%Should You Buy? - MarketBeat
RxSight (NASDAQ:RXST) Trading Down 1.6%Here's Why - MarketBeat
RxSight (NASDAQ:RXST) Trading Down 4.8%Should You Sell? - MarketBeat
Wells Fargo cuts RxSight rating, sees limited growth potential By Investing.com - Investing.com Nigeria
RxSight (NASDAQ:RXST) Shares Gap DownHere's Why - MarketBeat
Wells Fargo cuts RxSight rating, sees limited growth potential - Investing.com
RxSight (NASDAQ:RXST) Given "Equal Weight" Rating at Wells Fargo & Company - MarketBeat
RxSight downgraded to Equal Weight from Overweight at Wells Fargo - TipRanks
RxSight (NASDAQ:RXST) Trading Down 1.9%Here's What Happened - MarketBeat
Two Sigma Advisers LP Sells 119,200 Shares of RxSight, Inc. (NASDAQ:RXST) - MarketBeat
RxSight (NASDAQ:RXST) Trading Down 0.1%What's Next? - MarketBeat
Charles Schwab Investment Management Inc. Acquires 62,507 Shares of RxSight, Inc. (NASDAQ:RXST) - MarketBeat
RxSight (NASDAQ:RXST) Research Coverage Started at UBS Group - Defense World
RxSight, Inc. (NASDAQ:RXST) Shares Sold by Fmr LLC - MarketBeat
RxSight (NASDAQ:RXST) Stock Price Down 2%Time to Sell? - MarketBeat
UBS Initiates Coverage of RxSight (RXST) with Buy Recommendation - Nasdaq
UBS bullish on RxSight stock, projects 20%+ sales growth through 2028 - Investing.com Nigeria
RxSight Inc (RXST) Stock Price Up 3.84% on Dec 6 - GuruFocus.com
RxSight (NASDAQ:RXST) Coverage Initiated at UBS Group - MarketBeat
Finanzdaten der Rxsight Inc-Aktie (RXST)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.22%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):